Social economic costs of ankylosing spondylitis in Spain-Reference-Cited by-同舟云学术

Social economic costs of ankylosing spondylitis in Spain

Published:2021-04-09 Issue:2 Volume:39 Page:357-364
ISSN:1593-098X
Container-title:Clinical and Experimental Rheumatology
language:en
Short-container-title:

Author:

Merino María¹,Braçe Olta²,González-Domínguez Almudena³,Hidalgo-Vega Álvaro⁴,Garrido-Cumbrera Marco⁵,Gratacós Jordi⁶

Affiliation:

1. Weber, Madrid, Spain. maria.merino@weber.org.es

2. Health & Territory Research (HTR), Universidad de Sevilla, Spain.

3. Weber, Madrid, Spain.

4. Universidad de Castilla-La Mancha, Toledo, and Fundación Weber, Madrid, Spain.

5. Health & Territory Research (HTR), Universidad de Sevilla, and Spanish Federation of Spondyloarthritis Associations (CEADE), Fuenlabrada, Spain.

6. Rheumatology Department, University Hospital Parc Taulí, 13PT Research Institute (UAB), Sabadell, Barcelona; Medicine Department (UAB), Barcelona, Spain.

Publisher

Clinical and Experimental Rheumatology

Subject

Immunology,Immunology and Allergy,Rheumatology

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Retention Rate, Effectiveness, and Safety of Netakimab in the Treatment of Patients with Ankylosing Spondylitis: First Year Results of the LIBRA Post-Registration Safety Study;Doklady Biochemistry and Biophysics;2024-08-28

2. Regional Differences in Diagnosis Journey and Healthcare Utilization: Results from the International Map of Axial Spondyloarthritis (IMAS);Rheumatology and Therapy;2024-06-07

3. Dry and wet experiments reveal diagnostic clustering and immune landscapes of cuproptosis patterns in patients with ankylosing spondylitis;International Immunopharmacology;2024-01

4. Real-world retention rate, effectiveness, and safety of netakimab in the treatment of patients with ankylosing spondylitis: First year results of the LIBRA post-registration safety study;Rheumatology Science and Practice;2023-12-31

5. Association between air pollutants and initiation of biological therapy in patients with ankylosing spondylitis: a nationwide, population-based, nested case–control study;Arthritis Research & Therapy;2023-05-05